Market cap
$232.9m
End-of-day close multiplied by current shares on issue.
Equity lifted 85.9% to $39.9m and capex more than doubled to $1.8m, but the supplied prior comparable is FY21 full year, distorting headline changes.
Revenue context before the current result.
EBITDA margin across covered periods.
Operating cash flow across covered periods.
Operating working-capital absorption or release by reporting period.
Market context
A close-dated read on what the market price implies next to the latest verified filing inputs. Unavailable metrics stay visible when the absence is useful context.
The latest close and share count context for the market price.
Market cap
$232.9m
End-of-day close multiplied by current shares on issue.
How the market price compares with recent earnings and cash-flow inputs.
P/E
Not available
Not meaningful when recent earnings are negative.
EPS
-0.04
Recent filing-derived earnings per share.
PEG
Not available
Not available for this company right now.
EV/EBITDA
Not available
Not meaningful when recent EBITDA is negative.
P/FCF
Not available
Not meaningful when free cash flow is negative or unavailable.
P/B
9.11x
Market value compared with latest reported equity.
Yield and fund-style valuation where the company shape supports it.
Dividend yield
0.0%
Trailing dividends compared with the latest close.
Total return
Not available
Available once dividend and adjustment data are verified.
Key metrics
FY22 vs FY21
Revenue
$5.7m
-38.7% ↓ vs $9.3m
Net profit after tax
−$6.2m
+16.2% ↑ vs −$7.4m
Net cash inflow from operating activities
−$2.8m
+14.6% ↑ vs −$3.3m
Operating profit
−$6.2m
+16.0% ↑ vs −$7.4m
Profit before tax
−$6.2m
+16.2% ↑ vs −$7.4m
Cash and cash equivalents
$29.6m
+161.2% ↑ vs $11.3m
Total assets
$49.8m
+62.5% ↑ vs $30.7m
What changed
This makes the canonical year-on-year movements optically misleading: statutory revenue is down 38.7% to $5.7m and the loss narrowed 16.2% to $6.2m, but the prior figures span twelve months versus six. On a per-month basis, both the revenue base and the loss run-rate are higher than FY21.
Beyond the period mismatch, three movements stand out:
What matters
The $18.3m cash increase tracks the $18.4m equity increase almost exactly, and gross borrowings remain zero. This matters because the operating business is consuming cash at roughly $2.8m per half from operations plus another $1.8m of capex; the recapitalisation extends runway rather than reflecting an inflection in the underlying business model.
Investment intensity is stepping up while gross margin compresses. Capex grew 114.7% and gross margin fell to approximately 63% from 67% (commentary basis), a 400bps compression. This matters because the company is moving more aggressively on customer acquisition and capability build at the same time as unit economics on the current revenue mix are softening; the read is consistent with a growth investment phase but raises the bar on subsequent revenue acceleration.
Segment mix shows where the margin is. Platform Subscriptions, the dominant segment at 43.8% of revenue, runs an 84% gross margin against 43% on Platform Transactions and 50% on Hardware & Other. This matters because subscription growth is the only path to fix the blended margin compression; transaction and hardware revenue dilute it.
Expectations
Annualising HY22 revenue gives $11.4m, ahead of FY21's $9.3m, and management cites 40% constant-currency growth and "135% growth of new contracts won against pcp" plus contracted revenue "expected to be recognized over the next 12 months". The release supports a growth-phase trajectory, but does not quantify a path to profitability or a target year.
Because the supplied prior comparable in the structured data is FY21 full year, not HY21, conventional half-on-half comparability has to be inferred from management commentary rather than verified from the structured pass.
Quality of result
Underlying, the operating loss is $6.2m on $5.7m of revenue, free cash flow pre-lease is approximately -$4.6m (operating outflow of $2.8m plus $1.8m of capex), and operating cash conversion is negative because the business is not yet profitable. ROE of -15.6% looks less negative than FY21's -34.6%, but that improvement is driven by the enlarged equity base from the raise, not by earnings progress.
Working-capital signals are mixed: trade debtors fell 20.4% to $2.1m in dollars, but receivable days extended to 66.7 from 51.4 and inventory days to 35.3 from 22.4, because revenue contracted faster than the balances. None of this result is timing-driven in a way that flatters earnings; the durable read is that ikeGPS is loss-making at current scale and is funding the growth phase with shareholder capital.
Unresolved
This briefing cannot assess the underlying half-on-half operating trajectory with precision because the structured prior comparable is FY21 full year rather than HY21.
Chat
Ask follow-up questions about ikeGPS Group's FY22 result.
Informational only. No buy, sell, hold, price-target, or personal financial advice.
Informational only. No buy, sell, hold, price-target, or personal financial advice.
Open to load segment breakdown.
Open to load analytical metrics.
Open to load key metrics.
30 September 2021 Unaudited Interim Financial Statements
FY22 / financial reportIKE 1H FY22 Result Announcement
FY22 / results releaseResults Announcement
FY22 / results announcementcompany filing
FY21 / results announcementFY21 Financial results and Q1FY22 performance update
FY21 / results releaseikeGPS FY21 Financial Results
FY21 / financial reportcompany filing
FY21 / results announcementFY21 Financial results and Q1FY22 performance update
FY21 / results releaseikeGPS FY21 Financial Results
FY21 / financial reportCEO Presentation
FY22 / commentaryikeGPS 1H FY22 Results Presentation
FY22 / commentaryikeGPS FY21 results presentation and Q1FY22 update
FY22 / commentaryikeGPS Q1 FY22 performance update
FY22 / commentaryRelated insights
Cross-company views selected from the metrics in this briefing.
Revenue growth context
Revenue growth was -38.7% for this reporting period.
Working-capital pressure
Inventory days were 35 days, +13 days versus the prior comparable period.
ROE and capital efficiency
ROE was -15.6%, +19.0pp versus the prior comparable period.
Earnings quality and statutory distortions
PBT and NPAT growth diverged by 0.0pp.
Get the next ikeGPS Group briefing and related NZX reporting-season updates by email.